These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25680531)

  • 1. MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha.
    Wang X; Tan L; Lu Y; Peng J; Zhu Y; Zhang Y; Sun Z
    FEBS Lett; 2015 Mar; 589(6):726-9. PubMed ID: 25680531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
    Li J; Chen W; Yi Y; Tong Q
    J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-425-5p promotes tau phosphorylation and cell apoptosis in Alzheimer's disease by targeting heat shock protein B8.
    Yuan J; Wu Y; Li L; Liu C
    J Neural Transm (Vienna); 2020 Mar; 127(3):339-346. PubMed ID: 31919655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
    Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
    Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
    Pan K; Chen S; Wang Y; Yao W; Gao X
    Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
    Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
    CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
    Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
    Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathway.
    Xiong YS; Liu FF; Liu D; Huang HZ; Wei N; Tan L; Chen JG; Man HY; Gong CX; Lu Y; Wang JZ; Zhu LQ
    Aging Cell; 2015 Oct; 14(5):867-77. PubMed ID: 26111662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells.
    Kang Q; Xiang Y; Li D; Liang J; Zhang X; Zhou F; Qiao M; Nie Y; He Y; Cheng J; Dai Y; Li Y
    Oncotarget; 2017 Apr; 8(15):24314-24326. PubMed ID: 28186985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
    Hu M; Waring JF; Gopalakrishnan M; Li J
    J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
    Leroy K; Yilmaz Z; Brion JP
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation.
    Resende R; Ferreiro E; Pereira C; Oliveira CR
    J Neurosci Res; 2008 Jul; 86(9):2091-9. PubMed ID: 18335524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.
    Hu YK; Wang X; Li L; Du YH; Ye HT; Li CY
    Neurosci Bull; 2013 Dec; 29(6):745-51. PubMed ID: 23740209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease.
    Zhao ZB; Wu L; Xiong R; Wang LL; Zhang B; Wang C; Li H; Liang L; Chen SD
    Neuroscience; 2014 Sep; 275():232-7. PubMed ID: 24950120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease.
    Park H; Lee YB; Chang KA
    Int J Biol Sci; 2022; 18(5):2220-2234. PubMed ID: 35342350
    [No Abstract]   [Full Text] [Related]  

  • 20. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
    J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.